ES460321A1 - Metodo para la preparacion de mutante viral no virulento, del virus aujeszky. - Google Patents

Metodo para la preparacion de mutante viral no virulento, del virus aujeszky.

Info

Publication number
ES460321A1
ES460321A1 ES460321A ES460321A ES460321A1 ES 460321 A1 ES460321 A1 ES 460321A1 ES 460321 A ES460321 A ES 460321A ES 460321 A ES460321 A ES 460321A ES 460321 A1 ES460321 A1 ES 460321A1
Authority
ES
Spain
Prior art keywords
mutant
virus
aujeszky
production
dedo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES460321A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmachim DSO
Original Assignee
Pharmachim DSO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachim DSO filed Critical Pharmachim DSO
Publication of ES460321A1 publication Critical patent/ES460321A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES460321A 1976-07-02 1977-07-01 Metodo para la preparacion de mutante viral no virulento, del virus aujeszky. Expired ES460321A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG3365276 1976-07-02

Publications (1)

Publication Number Publication Date
ES460321A1 true ES460321A1 (es) 1978-11-01

Family

ID=3902412

Family Applications (1)

Application Number Title Priority Date Filing Date
ES460321A Expired ES460321A1 (es) 1976-07-02 1977-07-01 Metodo para la preparacion de mutante viral no virulento, del virus aujeszky.

Country Status (7)

Country Link
AR (1) AR216081A1 (enExample)
BE (1) BE856351A (enExample)
CA (1) CA1069821A (enExample)
ES (1) ES460321A1 (enExample)
FR (1) FR2356726A1 (enExample)
GB (1) GB1563284A (enExample)
NL (1) NL7707341A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3122669A1 (de) * 1980-06-12 1982-02-11 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld "verfahren zur herstellung von neuen mutanten von herpes simplex-viren typ 1 und typ 2"
HU187421B (en) * 1982-10-27 1986-01-28 Phylaxia Oltoanyagtermeloe Vallalat,Hu Process for producing inactivated, adjuvated serum against aujeszky's illness
US4514497B1 (en) * 1983-12-30 1998-02-24 Novagene Inc Modified live pseudorabies viruses

Also Published As

Publication number Publication date
NL7707341A (nl) 1978-01-04
CA1069821A (en) 1980-01-15
BE856351A (fr) 1977-10-31
GB1563284A (en) 1980-03-26
FR2356726B1 (enExample) 1981-01-16
AR216081A1 (es) 1979-11-30
FR2356726A1 (fr) 1978-01-27

Similar Documents

Publication Publication Date Title
FI880752A7 (fi) Neisseria gonorrhoeae-lektiinin käyttö rokotteena ja diagnostisena mer kkiaineena, sekä tämän lektiinintuotantomenetelmät.
IE37602L (en) Cyclocpentane derivatives
ATE38988T1 (de) Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
EP0014958B1 (en) Process for the preparation of 4,5-perfluoro-1,3-dioxolanes
BE853810A (fr) Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu
ES460321A1 (es) Metodo para la preparacion de mutante viral no virulento, del virus aujeszky.
FI793367A7 (fi) Menetelmä 1,2,3-tiadiatsol-5-yyli-virtsa-aineiden valmistamiseksi.
JPS51146432A (en) Process for preparation of benzanilide derivatives having therapeutic action to immunological disease
ATE10498T1 (de) Durch purinbasen substituierte alkylamino-desoxy1.4;3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
FR2297202A1 (fr) Procede de preparation de mono-(3'-hydroxy)-propionates du 1,3-propane-diol
ES446637A1 (es) Procedimiento para la preparacion de vacunas acelulares.
FR2299329A1 (fr) Procede de preparation de 1,2-benzisothiazoles
JPS5258335A (en) Program extending method by rom cassette system
PT82020B (pt) Processo para a preparacao de eter 4-(2-metoxietil)-fenilglicidilico e/ou metoprolol
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
KR880001630A (ko) 5-플루오로우라실 유도체 및 그의 용도
FR2295952A1 (fr) Procede de preparation d'acide 3,6-dichloropicolinique
BE843500A (fr) Procede de preparation d'oxaphospholannes-1,2,
JPS51127221A (en) Preparation of carbonaceous fibers
DE3264316D1 (en) Vaccine against foot-and-mouth disease and colibacillosis, and process for preparing it
FR2310335A1 (fr) Procede de preparation de 3,5-ditertiobutyl-4-hydroxybenzaldehyde a partir d'alcool 3,5-ditertiobutyl-4-hydroxybenzylique
FR2580176B1 (fr) Vaccin antirabique avirulent
USD236248S (en) sntble
SU502900A1 (ru) "Способ получени производных -алкилоксаазафосфоринанов-1,3,2
JPS5236635A (en) Process for preparation of 4-(3'- dimethylaminopropoxy)-meta- phenylen ediamine